Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Stinchcombe

Showing results (1-10 of 199) with videos related to

Pageof 20
Sort By:
Biologics : Targets & Therapy|August 27, 2009
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumabThomas E Stinchcombe
Translational Lung Cancer Research|August 14, 2023
Selpercatinib in patients with <i>RET</i> fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trialThomas E Stinchcombe
Nanomedicine (London, England)|August 25, 2007
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxelThomas E Stinchcombe
Translational Lung Cancer Research|March 10, 2016
AZD9291 in epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancerThomas E Stinchcombe
Medical Oncology (Northwood, London, England)|April 22, 2014
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapyThomas E Stinchcombe
F1000Prime Reports|January 13, 2015
Recent advances in the treatment of non-small cell and small cell lung cancerThomas E Stinchcombe
Translational Lung Cancer Research|December 13, 2024
Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?Thomas E Stinchcombe
Therapeutic Advances in Medical Oncology|August 13, 2020
Current management of <i>RET</i> rearranged non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung CancerThomas E Stinchcombe
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel formulations and new mechanisms of delivering chemotherapyThomas E Stinchcombe
Pageof 20

Showing results (1-10 of 199) with videos related to

Sort By:
Pageof 20
Biologics : Targets & Therapy|August 27, 2009
Targeted therapy of advanced non-small cell lung cancer: the role of bevacizumabThomas E Stinchcombe
Translational Lung Cancer Research|August 14, 2023
Selpercatinib in patients with <i>RET</i> fusion positive non-small cell lung cancer: updated follow-up of the LIBRETTO-001 phase I/II trialThomas E Stinchcombe
Nanomedicine (London, England)|August 25, 2007
Nanoparticle albumin-bound paclitaxel: a novel Cremphor-EL-free formulation of paclitaxelThomas E Stinchcombe
Translational Lung Cancer Research|March 10, 2016
AZD9291 in epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancerThomas E Stinchcombe
Medical Oncology (Northwood, London, England)|April 22, 2014
Unmet needs in squamous cell carcinoma of the lung: potential role for immunotherapyThomas E Stinchcombe
F1000Prime Reports|January 13, 2015
Recent advances in the treatment of non-small cell and small cell lung cancerThomas E Stinchcombe
Translational Lung Cancer Research|December 13, 2024
Epidermal growth factor receptor exon 20 insertion mutations: are we getting closer to solving the puzzle?Thomas E Stinchcombe
Therapeutic Advances in Medical Oncology|August 13, 2020
Current management of <i>RET</i> rearranged non-small cell lung cancerThomas E Stinchcombe
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2023
Flashback Foreword: Docetaxel Versus Best Supportive Care in Non-Small-Cell Lung Cancer and Pemetrexed Versus Docetaxel in Second-Line Non-Small-Cell Lung CancerThomas E Stinchcombe
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2014
Novel formulations and new mechanisms of delivering chemotherapyThomas E Stinchcombe
Pageof 20